Immunocompromised Status Definition in Observational Studies Using Electronic Health Records: A Scoping Review and a Proposal for a Phenotype Identification Algorithm
Pharmacoepidemiology and Drug Safety · 2026
DOI: 10.1002/pds.70362 ↗Kurz gefasst
Scoping Review in der Zeitschrift Pharmacoepidemiology and Drug Safety, 2026. Verfasst von Judit Riera-Arnau und 17 weiteren Autor:innen. Beteiligte Einrichtung: Department of Data Science and Biostatistics, Julius Center for Health Sciences and Primary Care, University Medical Center Utrecht (UMCU), Utrecht, …. Hauptthemen laut MEDLINE: Electronic Health Records, Algorithms, Immunocompromised Host, Observational Studies as Topic. Die Arbeit nennt 45 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: European Medicines Agency.
Abstract (Originalsprache)
Immunocompromised individuals experience an impaired immune function due to conditions that might be either congenital or acquired over the course of their lives. Epidemiological studies often rely on clinical definitions which, in some cases, benefit from being translated into machine‐readable algorithms for application to electronic health records (EHRs) databases. The transient nature of certain immunocompromised states and the variability of phenotypes, definitions, coding practices, and data availability entangle this operation. To address these challenges, we conducted a scoping review of existing immunocompromised status definitions in MEDLINE, focusing on epidemiologic and pharmacoepidemiologic studies involving immunocompromised populations. Data extraction was guided by clinical experts, categorizing conditions and medications into seven categories: genetic/hereditary conditions, infectious diseases, malignancies and chemotherapy, organ and stem‐cell transplantations, severe systemic conditions, immunosuppressive drugs, and autoimmune conditions associated with immunosuppressant use. Out of 137 citations, 56 studies were included. Most of the studies focused on a particular disease or therapeutic area. Frequently cited diagnoses included HIV/AIDS (17.9%) and organ transplantation (14.2%). Methotrexate, corticosteroids, TNF‐alpha inhibitors, and calcineurin inhibitors were the most common drugs used to define immunocompromised status. Building on this review and expert opinion, we developed a phenotype algorithm that combines diagnostic, therapeutic, and procedural data in a modular way to identify immunocompromised populations in EHR data sources. The proposed phenotype algorithm can be applied across diverse data sources, settings and research questions. Future research should test its applicability across heterogeneous EHR data sources.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Data Science and Biostatistics, Julius Center for Health Sciences and Primary Care, University Medical Center Utrecht (UMCU), Utrecht, the Netherlands.
- Department of Clinical Pharmacology, Vall Hebron Institut de Recerca (VHIR), Universitat Autònoma de Barcelona (UAB), Barcelona, Spain.
- Department of Medicine, University of Verona, Verona, Italy.
- Partnerships, Barcelona Health Hub, Teamit Institute, Barcelona, Spain.
- Fundació Institut Universitari per a la Recerca a l'Atenció Primària de Salut Jordi Gol i Gurina (IDIAPJGol), Barcelona, Spain.
- Department of Clinical Epidemiology and Department of Clinical Medicine, Aarhus University and Aarhus University Hospital, Aarhus, Denmark.
ORCID-Profile: Judit Riera-Arnau, Fabio Riefolo, Martín Solorzano, Irene Pazos, Elena Ballarín, Lise Skovgaard Svingel, Lorenzo Chiusaroli, Elisa Martín-Merino, Sima Mohammadi, Carlos E Durán
Förderung
- European Medicines Agency
Zitieren
APA
Riera-Arnau, J., Luxi, N., Riefolo, F., Solorzano, M., Pazos, I., Ballarín, E., Svingel, L. S., Chiusaroli, L., Martín-Merino, E., Barbieri, E., Lopez-Lasanta, M., Mohammadi, S., Rotta, D., Pacurariu, A., Cohet, C., Sturkenboom, M., Durán, C. E., & SAFETY‐VAC study consortium (2026). Immunocompromised Status Definition in Observational Studies Using Electronic Health Records: A Scoping Review and a Proposal for a Phenotype Identification Algorithm. Pharmacoepidemiology and Drug Safety. https://doi.org/10.1002/pds.70362
Vancouver
Riera-Arnau J, Luxi N, Riefolo F, Solorzano M, Pazos I, Ballarín E, et al. Immunocompromised Status Definition in Observational Studies Using Electronic Health Records: A Scoping Review and a Proposal for a Phenotype Identification Algorithm. Pharmacoepidemiology and Drug Safety. 2026. doi:10.1002/pds.70362
BibTeX
@article{RieraArnau2026,
author = {Riera-Arnau, Judit and Luxi, Nicoletta and Riefolo, Fabio and Solorzano, Martín and Pazos, Irene and Ballarín, Elena and Svingel, Lise Skovgaard and Chiusaroli, Lorenzo and Martín-Merino, Elisa and Barbieri, Elisa and Lopez-Lasanta, María and Mohammadi, Sima and Rotta, Denis and Pacurariu, Alexandra and Cohet, Catherine and Sturkenboom, Miriam and Durán, Carlos E and SAFETY‐VAC study consortium, SAFETY‐VAC study consortium},
title = {Immunocompromised Status Definition in Observational Studies Using Electronic Health Records: A Scoping Review and a Proposal for a Phenotype Identification Algorithm},
journal = {Pharmacoepidemiology and Drug Safety},
year = {2026},
doi = {10.1002/pds.70362}
}
EUVIMED